 |  |
| ABX | ||
| 2,696.722 | ||
| 7.4050 | 0.0028% | |
| BISNIS-27 | ||
| 410.819 | ||
| 6.6100 | 0.0164% | |
| DBX | ||
| 2,826.478 | ||
| 1.3960 | 0.0005% | |
| ECONOMIC30 | ||
| 82.849 | ||
| 1.7970 | 0.0222% | |
| ESGQKEHATI | ||
| 100.114 | ||
| 1.7780 | 0.0181% | |
| ESGSKEHATI | ||
| 101.225 | ||
| 1.8050 | 0.0182% | |
| I-GRADE | ||
| 148.588 | ||
| 2.9600 | 0.0203% | |
| AUDRP | ||
| 12,476.930 | ||
| -33.3200 | -0.2663% | |
| EURRP | ||
| 20,534.080 | ||
| -47.0900 | -0.2288% | |
| JPYRP | ||
| 110.922 | ||
| -0.0449 | -0.0405% | |
| SINRP | ||
| 13,902.440 | ||
| -9.8600 | -0.0709% | |
| USDRP | ||
| 17,955.000 | ||
| -35.0000 | -0.1946% | |
Pandemi COVID-19 mendorong Indonesia untuk memproduksi obat-obatan dan alat kesehatan (alkes) secara mandiri. Pemerintah mengupayakan ketergantungan terhadap produk impor berkurang hingga 35 persen pada akhir 2022.
